Efficacy and safety of ultra‐rapid lispro versus lispro in children and adolescents with type 1 diabetes: The <scp>PRONTO‐Peds trial</scp>-Reference-Cited by-同舟云学术

Efficacy and safety of ultra‐rapid lispro versus lispro in children and adolescents with type 1 diabetes: The PRONTO‐Peds trial

Author:

Wadwa R. Paul¹,Laffel Lori M.²,Franco Denise R.³,Dellva Mary Anne⁴,Knights Alastair W.⁴,Pollom Robyn K.⁴^ORCID

Affiliation:

1. Barbara Davis Center for Diabetes University of Colorado Anschutz Medical Campus Aurora Colorado

2. Joslin Diabetes Center Harvard Medical School Boston Massachusetts

3. CPCLIN/DASA Clinical Research Center São Paulo Brazil

4. Eli Lilly and Company Indianapolis Indiana

Funder

Eli Lilly and Company

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

Reference21 articles.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

2. New Insulins, Biosimilars, and Insulin Therapy;Diabetes Technology & Therapeutics;2024-03-01

3. Preoperative Patient Evaluation;Anesthesiology Clinics;2024-03